Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
about
Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literatureUsing the neurofibromatosis tumor predisposition syndromes to understand normal nervous system development.Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.Ophthalmological assessment of children with neurofibromatosis type 1.Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.Manifestations of pilocytic astrocytoma: a pictorial review.Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.Optic pathway glioma in children: 10 years of experience in a single institution.Optic pathway glioma as part of a constitutional mismatch-repair deficiency syndrome in a patient meeting the criteria for neurofibromatosis type 1.Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.Optic Pathway Gliomas in Neurofibromatosis Type 1.Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1.Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.Visual acuity of children treated with chemotherapy for optic pathway gliomas.Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.Evaluation and Management of Optic Pathway Gliomas
P2860
Q26775950-C5E70AA5-4A04-46FC-AF67-88F7B4A980FDQ34176631-2A12BD69-B0D5-4E44-8DAA-ED4EDFA350E9Q36010097-9C87F73A-FCCE-4217-B832-B0DE1EB5A42BQ38109483-6BF0F784-7FD9-4CF8-87B6-71E2D1F0FFDFQ38124008-5518F18A-2A24-47B7-B2DC-408098F31D6FQ38208755-29F321C9-B0EC-4A3E-8954-DE81E1F07C25Q39677669-9B58321C-2EE9-419D-8F7F-C62622B827E5Q39895203-9378F7AD-1B09-4CFD-9FDC-550E650D6387Q44965675-738AFEC1-0B98-4AE2-99D6-BB7A63942E08Q47743242-A95A5444-B014-461F-9D02-87152BD64220Q47779215-CFFBA1F8-B9B8-4EE7-968C-D9B0BD8E2EE3Q53143705-18B43E32-27DA-495F-9899-4165C14B368CQ55253583-81B6E7EE-7BFE-4DC9-825E-F5A27ED7E06CQ55461513-F4DC7E95-B083-4B4F-B0E5-B7AECF0E7723Q55463290-465BCD4B-DC39-4FEC-9DEA-90DECFDE39E4Q58920710-2D8B3423-7B26-4CE4-A69B-8F3467442C49
P2860
Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@en
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@nl
type
label
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@en
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@nl
prefLabel
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@en
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@nl
P2093
P1476
Optic pathway gliomas in patie ...... e 1: follow-up of 44 patients.
@en
P2093
June Ortenberg
Laura Segal
Mahshad Darvish-Zargar
Marie-Emmanuelle Dilenge
Robert C Polomeno
P304
P356
10.1016/J.JAAPOS.2009.11.020
P577
2010-04-01T00:00:00Z